WFSBP Programme 2015

76 / 112

74
WFSBP 2015
Scientific Programme | Thursday, 18 June 2015
PL-04 Plenary Lecture
10:00–10:45 Trianti Hall
Chair: Martin Hatzinger, Switzerland
PL-04-001
Neurobiological correlates of fear and anxiety and their
clinical implications
Kerry Ressler, USA
T16: Genetics
S-45 Symposium
08:30–10:00 Trianti Hall
Advances in genetics of affective disorders
Chair: George N. Papadimitriou, Greece
S-45-001
Update on genetics of affective disorders
Dimitris Dikeos, Greece
S-45-002
Pharmacogenetics of antidepressants
Alessandro Serretti, Italy
C. Fabbri
S-45-003
Organization and administration of a multinational project
on pharmacogenetics
Daniel Surrey, Belgium
S-45-004
Overview of the field and critical appraisals
Thomas Schulze, Germany
T44: Stimulation Methods (ECT, TMS, VNS, DBS)
S-46 Symposium
08:30–10:00 Mitropoulos Hall
The latest international findings regarding TMS for treat-
ing depression
Chair: Paul Fitzgerald, Australia
Co-Chair: Mark George, USA
S-46-001
New data on acute phase treatments–dosing paradigms,
improving speed of response, coil designs
Paul Fitzgerald, Australia
Z. J. Daskalakis
S-46-002
How durable are TMS antidepressant effects? New data
Mark Demitrack, USA
S-46-003
Combining TMS with CBT or medications to boost response
Michael Thase, USA
S-46-004
The latest advances in understanding TMS antidepressant
neurobiology
Shinsuke Kito, Japan
T40: Schizophrenia: Basic/ Clinical
S-47 Symposium
08:30–10:00 Skalkotas Hall
Defining and re-defining the boundaries of psychotic
disorders using neuroimaging
Chair: Christos Pantelis, Australia
Co-Chair: Eva Meisenzahl, Germany
S-47-001
Decomposing schizophrenia into intermediate imaging
phenotypes identified by multiple system mapping
Henrik Walter, Germany
S-47-002
Identifying neuroanatomical signatures of schizophrenia
phenotypes using novel imaging methods
Christos Davatzikos, USA
S-47-003
Stratifying schizophrenia according to outcome using MRI-
based pattern classification methods
Paola Dazzan, United Kingdom
S-47-004
Commonalities and differences between schizophrenia and
neurodegenerative disorders elucidated by neuroimaging
Dennis Velakoulis, Australia
T22: Neuropathology
S-48 Symposium
08:30–10:00 MC 3 Room
Understanding psychiatric disorders: Recent advances
in postmortem research
Chair: Brian Dean, Australia
Co-Chair: Elizabeth Scarr, Australia
S-48-001
Structural and molecular alterations of the hippocampus
in schizophrenia
Peter Falkai, Germany
S-48-002
Roles for immune-regulated genes and neurotransmitter
receptors in the pathophysiology of psychiatric disorders
Brian Dean, Australia